Class-specific histone/protein deacetylase inhibition protects against renal ischemia reperfusion injury and fibrosis formation

American Journal of Transplantation

Volumn 15, Issue 4, 2015, Pages 965-973

  Levine, M H ^a,b   Wang, Z ^a   Bhatti, T R ^b   Wang, Y ^a   Aufhauser, D D ^a   McNeal, S ^a   Liu, Y ^b   Cheraghlou, S ^a   Han, R ^b   Wang, L ^b   Hancock, W W ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

basic (laboratory) research science; genetics; ischemia reperfusion injury (IRI); kidney failure injury; kidney transplantation nephrology; molecular biology; molecular biology: micro RNA; pathology histopathology; tissue injury and repair

Indexed keywords

ENTINOSTAT; HEAT SHOCK PROTEIN; HISTONE DEACETYLASE; MICRORNA 21; HISTONE; HISTONE DEACETYLASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; DRUG TARGETING; ENZYME INHIBITION; GENE CONTROL; HEAT SHOCK RESPONSE; HISTONE ACETYLATION; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; ANIMAL; C57BL MOUSE; FEMALE; FIBROSIS; ISCHEMIA; KIDNEY; METABOLISM; VASCULARIZATION;

ANIMALS; FEMALE; FIBROSIS; HISTONE DEACETYLASE INHIBITORS; HISTONES; ISCHEMIA; KIDNEY; MICE; MICE, INBRED C57BL; REPERFUSION INJURY;

EID: 84925331436     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13106     Document Type: Article

References (53)

1. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL., Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-974.
2. Perco P, Pleban C, Kainz A, Lukas A, Mayer B, Oberbauer R., Gene expression and biomarkers in renal transplant ischemia reperfusion injury. Transpl Int 2007; 20: 2-11.
3. Tilney NL, Guttmann RD., Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997; 64: 945-947.
4. Audard V, Matignon M, Dahan K, Lang P, Grimbert P., Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview. Transpl Int 2008; 21: 11-17.
5. Kosieradzki M, Rowinski W., Ischemia/reperfusion injury in kidney transplantation: Mechanisms and prevention. Transplant Proc 2008; 40: 3279-3288.
6. Meier-Kriesche HU, Schold JD, Kaplan B., Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies ? Am J Transplant 2004; 4: 1289-1295.
7. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR., The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
8. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB., Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590.
9. Wolfe RA, Roys EC, Merion RM., Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant 2010; 10: 961-972.
10. Meier-Kriesche HU, Baliga R, Kaplan B., Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291-1295.
11. Gregoretti IV, Lee YM, Goodson HV., Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis. J Mol Biol 2004; 338: 17-31.
12. Choudhary C, Kumar C, Gnad F, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009; 325: 834-840.
13. Grozinger CM, Hassig CA, Schreiber SL., Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 1999; 96: 4868-4873.
14. Spange S, Wagner T, Heinzel T, Kramer OH., Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 2009; 41: 185-198.
15. Scroggins BT, Robzyk K, Wang D, et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell 2007; 25: 151-159.
16. Westerheide SD, Morimoto RI., Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 2005; 280: 33097-33100.
17. Zhang PL, Lun M, Schworer CM, et al. Heat shock protein expression is highly sensitive to ischemia-reperfusion injury in rat kidneys. Ann Clin Lab Sci 2008; 38: 57-64.
18. Vanhooren V, Liu XE, Desmyter L, et al. Over-expression of heat shock protein 70 in mice is associated with growth retardation, tumor formation, and early death. Rejuvenation Res 2008; 11: 1013-1020.
19. Westerheide SD, Kawahara TL, Orton K, Morimoto RI., Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 2006; 281: 9616-9622.
20. Klettner A., The induction of heat shock proteins as a potential strategy to treat neurodegenerative disorders. Drug News Perspect 2004; 17: 299-306.
21. Hunt CR, Dix DJ, Sharma GG, et al. Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice. Mol Cell Biol 2004; 24: 899-911.
22. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH., Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 1995; 95: 1446-1456.
23. Harrison EM, Sharpe E, Bellamy CO, et al. Heat shock protein 90-binding agents protect renal cells from oxidative stress and reduce kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 2008; 295: F397-405.
24. Bidmon B, Endemann M, Muller T, Arbeiter K, Herkner K, Aufricht C., Heat shock protein-70 repairs proximal tubule structure after renal ischemia. Kidney Int 2000; 58: 2400-2407.
25. Wang L, Tao R, Hancock WW., Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. Immunol Cell Biol 2009; 87: 195-202.
26. Park JH, Jung Y, Kim TY, et al. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res 2004; 10: 5271-5281.
27. Zhang ZY, Zhang Z, Schluesener HJ., MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis. Neuroscience 2010; 169: 370-377.
28. Chiechio S, Zammataro M, Morales ME, et al. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol 2009; 75: 1014-1020.
29. Wang JJ, Hockenheimer S, Bickerstaff AA, Hadley GA., Murine renal transplantation procedure. J Vis Exp 2009; 29: 1150.
30. Tao R, de Zoeten EF, Ozkaynak E, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007; 13: 1299-1307.
31. Akimova T, Xiao H, Liu Y, et al. Targeting sirtuin-1 alleviates experimental autoimmune colitis by induction of Foxp3 T-regulatory cells. Mucosal Immunol 2014; 7: 1209-1220.
32. Beier UH, Akimova T, Liu Y, Wang L, Hancock WW., Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. Curr Opin Immunol 2011; 23: 670-678.
33. Beier UH, Wang L, Han R, Akimova T, Liu Y, Hancock WW., Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci Signal 2012; 5: ra45.
34. Beier UH, Wang L, Hancock WW., Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell function. Cell Cycle 2012; 11 (18): 3351-3352.
35. Wang L, de Zoeten EF, Greene MI, Hancock WW., Immunomodulatory effects of deacetylase inhibitors: Therapeutic targeting of FOXP3+ regulatory T cells. Nat Rev Drug Discov 2009; 8: 969-981.
36. Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J., Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 2010; 107: 14339-14344.
37. Hampton CR, Shimamoto A, Rothnie CL, et al. HSP70.1 and -70.3 are required for late-phase protection induced by ischemic preconditioning of mouse hearts. Am J Physiol Heart Circ Physiol 2003; 285: H866-874.
38. Ferenbach DA, Kluth DC, Hughes J., Hemeoxygenase-1 and renal ischaemia-reperfusion injury. Nephron Exp Nephrol 2010; 115: e33-37.
39. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV., Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266.
40. Shapiro MD, Bagley J, Latz J, et al. MicroRNA expression data reveals a signature of kidney damage following ischemia reperfusion injury. PLoS One 2011; 6: e23011.
41. Marumo T, Hishikawa K, Yoshikawa M, Hirahashi J, Kawachi S, Fujita T., Histone deacetylase modulates the pro-inflammatory and fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 2010; 298: F133-F141.
42. Pang M, Kothapally J, Mao H, et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2009; 297: F996-F1005.
43. He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 2010; 120: 1056-1068.
44. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A., Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112: 1486-1494.
45. Sugiura H, Yoshida T, Mitobe M, et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant 2010; 25: 60-68.
46. Wang Z, Gall JM, Bonegio RG, et al. Induction of heat shock protein 70 inhibits ischemic renal injury. Kidney Int 2011.
47. Yeh CH, Hsu SP, Yang CC, Chien CT, Wang NP., Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy. Life Sci 2010; 86: 115-123.
48. Chen SW, Kim M, Kim M, et al. Mice that overexpress human heat shock protein 27 have increased renal injury following ischemia reperfusion. Kidney Int 2009; 75: 499-510.
49. Kim BS, Lim SW, Li C, et al. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 2005; 79: 1370-1377.
50. O'Neill S, Ross JA, Wigmore SJ, Harrison EM., The role of heat shock protein 90 in modulating ischemia-reperfusion injury in the kidney. Expert Opin Investig Drugs 2012; 21: 1535-1548.
51. Cianciolo Cosentino C, Skrypnyk NI, Brilli LL, et al. Histone deacetylase inhibitor enhances recovery after AKI. J Am Soc Nephrol 2013; 24: 943-953.
52. de Groh ED, Swanhart LM, Cosentino CC, et al. Inhibition of histone deacetylase expands the renal progenitor cell population. J Am Soc Nephrol 2010; 21: 794-802.
53. Glaser KB, Li J, Pease LJ, et al. Differential protein acetylation induced by novel histone deacetylase inhibitors. Biochem Biophys Res Commun 2004; 325: 683-690.